NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A
NCT05633355 A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE3
NCT05624112 Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China Status COMPLETED Phase PHASE4
NCT05614817 CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis Status WITHDRAWN Phase PHASE3
NCT05613062 Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children Status UNKNOWN Phase PHASE1/PHASE2
NCT05608343 This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD) Status COMPLETED Phase PHASE3
NCT05602207 Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab Status COMPLETED Phase PHASE4
NCT05601882 A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT05598762 The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape Strips Status UNKNOWN Phase NA
NCT05583019 Atopic Dermatitis With Accelerometry and Polysomnography (ADAP) Status COMPLETED Phase N/A
NCT05579925 A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis Status COMPLETED Phase PHASE2
NCT05578482 Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis Status UNKNOWN Phase PHASE4
NCT05575882 Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin. Status RECRUITING Phase NA
NCT05571943 A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT05566262 Bodewell Products for the Treatment of Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05559359 A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05544448 In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases Status COMPLETED Phase NA
NCT05531188 Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic Dermatitis Status COMPLETED Phase N/A
NCT05530707 Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using Moisturizer Status COMPLETED Phase NA
NCT05527964 A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech Republic Status COMPLETED Phase N/A